Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cara Therapeutics Inc CARA

Healthcare Cannabis
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated... see more

Recent & Breaking News (NDAQ:CARA)

Factors of Influence in 2018, Key Indicators and Opportunity within Camden National, Cara Therapeutics, Albany International, Emerge Energy Services LP, Fiesta Restaurant Group, and Resources Connection — New Research Emphasizes Economic Growth

GlobeNewswire June 21, 2018

International Cannabis Legalization to Spur Global Medical and Recreational Sales

PR Newswire June 13, 2018

Cara Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

GlobeNewswire May 29, 2018

Mid-Day Market Update: Dow Falls Over 100 Points; Cara Therapeutics Shares Spike Higher

Benzinga.com  May 23, 2018

Cara Therapeutics Shares Jump On Licensing Deal For Pruritis Treatment

Benzinga.com  May 23, 2018

Mid-Morning Market Update: Markets Open Lower; Target Earnings Miss Views

Benzinga.com  May 23, 2018

Benzinga Pro's 5 Stocks To Watch Today

Benzinga.com  May 23, 2018

Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensing Agreement to Commercialize KORSUVA™ Injection in Dialysis Patients with Pruritus

GlobeNewswire May 23, 2018

The Value of Legal Cannabis Market Projected to Grow

PR Newswire May 15, 2018

Cara Therapeutics to Present at the International Investigative Dermatology 2018 Meeting 

GlobeNewswire May 14, 2018

Cara Therapeutics Reports First Quarter 2018 Financial Results

GlobeNewswire May 9, 2018

Cara Therapeutics to Announce First Quarter 2018 Financial Results on May 9, 2018

GlobeNewswire May 2, 2018

Research Report Identifies Cara Therapeutics, MGE Energy, IDEXX Laboratories, Sterling Construction, TTM Technologies, and Regis with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire April 30, 2018

Data Shows Medical Cannabis Market Sales are Projected to Grow

PR Newswire April 27, 2018

Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation

GlobeNewswire April 10, 2018

Medical and Legal Cannabis Markets are Projected to Increase in Value

PR Newswire March 23, 2018

Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire March 15, 2018

Cara Therapeutics Inc to Host Earnings Call

Accesswire March 15, 2018

Data Shows that Medical Cannabis Sales are set to Rise

PR Newswire March 9, 2018

Cara Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018

GlobeNewswire March 8, 2018